Maha A. Assi, Matthew J. Binnicker, Nancy L. Wengenack, Paul J. Deziel, Andrew D. Badley – 25 July 2006 – Coccidioidomycosis has been previously described in recipients of solid organ transplantation, especially in patients who have lived in or have visited areas endemic for Coccidioides spp. We present a case of coccidioidomycosis in a liver transplant recipient with several unique aspects, including negative serology and positive polymerase chain reaction results. Liver Transpl 12:1290–1292, 2006. © 2006 AASLD.

Evan G. Pivalizza, Steven I. Abramson, Nicholas C. Lam, Robert D. Warters – 25 July 2006

Luc Massicotte, Serge Lénis, Lynda Thibeault, André Roy – 25 July 2006

Luc Massicotte, Serge Lénis, Lynda Thibeault, Marie‐Pascale Sassine, Robert F. Seal, Andre Roy – 25 July 2006

Yasumasa Shirouzu, Mureo Kasahara, Daisuke Morioka, Seisuke Sakamoto, Kaoru Taira, Kenji Uryuhara, Kohei Ogawa, Yasutsugu Takada, Hiroto Egawa, Koichi Tanaka – 25 July 2006 – Smaller‐size infants undergoing living‐donor liver transplantation (LDLT) are at increased risks of vascular complications because of their smaller vascular structures in addition to vascular pedicles of insufficient length for reconstruction. Out of 585 child patients transplanted between June 1990 and March 2005, 64 (10%) weighing less than 6 kg underwent 65 LDLTs.

Francis Y. Yao – 25 July 2006

Claude Lentschener, Annick Steib – 25 July 2006

Norah A. Terrault, Marina Berenguer – 25 July 2006 – Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United States and Europe. Unfortunately, although transplantation is effective for treating decompensated cirrhosis and limited hepatocellular carcinoma associated with hepatitis C, HCV reinfection is virtually the rule among transplant recipients.

25 July 2006

Federico Aucejo, Charles Miller, David Vogt, Bijan Eghtesad, Shunichi Nakagawa, James K. Stoller – 25 July 2006 – Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct clinical entities that may complicate liver disease. Although HPS and PPHTN are different, several reports describe 6 patients in whom both conditions have occurred, either concurrently or sequentially, sometimes with the onset of PPHTN after liver transplantation.